Acute Porphyria Drug Database

Monograph

D10AD03 - Adapalene
Propably not porphyrinogenic
PNP

Rationale
No data on metabolism. Probably insignificant systemic exposure in dermal use.
Chemical description
Adapalene gel / creme 0.1% for dermal use in acne vulgaris. Retinoidelike substance with antiinflammatory action. Low percutaneous absorbtion, plasma levels below 0.15 ng/ml.

Similar drugs
Explore alternative drugs in similar therapeutic classes D10A / D10AD or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Netherlands
Differin · Differin Gel 1 mg/g, gel
Belgium
Differin · Differin 0.1 % crème · Differin Gel 0.1 % gel
United Kingdom
Adapalene · Adapalene 0.1% cream · Adapalene 0.1% gel · Differin · Differin 0.1% cream · Differin 0.1% gel
Denmark
Adapalen · Adapalen "2care4" · Redap
Norway
Differin
Poland
Acnelec · Differin
Luxembourg
DIFFERIN
Iceland
Differin
Finland
Differin
Latvia
Differin · Differine
Serbia
SONA · SONA®
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙